NCR2

Oddi ar Wicipedia
Jump to navigation Jump to search
Natural cytotoxicity triggering receptor 2
Dynodwyr
Cyfenwaulymphocyte antigen 95 (activating NK-receptor; NK-p44)NK-p44NK cell-activating receptorlymphocyte antigen 95 homolog (activating NK-receptor; NK-p44)NKp44natural killer cell p44-related proteinNCR2NK cell activating receptor (NKp44)natural cytotoxicity triggering receptor 2Lymphocyte antigen 95 homolog
Dynodwyr allanolGeneCards: [1]
Orthologau
SpeciesBod dynolLlygoden
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Lleoliad (UCSC)n/an/a
PubMed searchn/an/a
Wicidata
Gweld/Golygu Bod dynol

Protein sy'n cael ei godio yn y corff dynol gan y genyn NCR2 yw NCR2 a elwir hefyd yn Natural cytotoxicity triggering receptor 2 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 6, band 6p21.1.[1]

Cyfystyron[golygu | golygu cod y dudalen]

Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn NCR2.

  • LY95
  • CD336
  • NKP44
  • NK-p44
  • dJ149M18.1

Llyfryddiaeth[golygu | golygu cod y dudalen]

  • "Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes. ". Cell Immunol. 2013. PMID 24044960.
  • "Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. ". Proc Natl Acad Sci U S A. 2013. PMID 23818644.
  • "Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. ". J Invest Dermatol. 2014. PMID 24658504.
  • "Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. ". J Invest Dermatol. 2014. PMID 24352038.
  • "Augmenting the expression of NKp44 molecule and the natural killer activity in peripheral blood mononuclear cells from patients with malignant colorectal carcinoma.". Drug Res (Stuttg). 2014. PMID 24154937.

Cyfeiriadau[golygu | golygu cod y dudalen]